![]() |
市場調査レポート
商品コード
1797673
組織接着剤の世界市場:タイプ・用途・エンドユーザー・地域別 (~2035年)Global Tissue Adhesives Market Research Report by Type, by Application, by End User, and by Region Forecast till 2035 |
||||||
|
組織接着剤の世界市場:タイプ・用途・エンドユーザー・地域別 (~2035年) |
出版日: 2025年07月16日
発行: Market Research Future
ページ情報: 英文 181 Pages
納期: 即納可能
![]() |
世界の組織接着剤の市場規模は、予測期間中にCAGR 9.06%で推移し、2035年には68億9,000万米ドルに達すると予測されています。
組織接着剤は医療用に特化した接着剤で、主に皮膚の創傷閉鎖に有用です。組織に強固かつ確実に結合することで、従来よりも侵襲性の低い創傷閉鎖方法を提供し、結果として治癒の迅速化や審美的な仕上がりの向上につながります。
生体模倣型、ナノテクノロジー強化型、ポリマー系接着剤の革新が創傷閉鎖のあり方を変革しています。これらの進歩により、結合強度の向上、閉鎖時間の短縮、感染リスクの低減が実現され、組織接着剤は現代の低侵襲手術において不可欠な存在となっています。さらに、ゲルやスプレーといった改良型の投与システムは導入を加速させており、次世代型接着剤は、患者中心の効率的かつ持続可能な外科医療の基盤として世界的に位置づけられています。
地域別インサイト
北米は依然として最大の地域市場であり、世界全体の収益シェアの40%以上を占めています。心血管外科、整形外科、再建外科の症例数の多さにより、組織接着剤は現代外科手術において必須の存在となっています。米国は2024年に9億1,372万米ドルで北米市場を支配し、カナダが1億9,990万米ドルで続いています。米国が大陸で最も強力な市場であり続けているのは、大規模な研究開発投資と新しいバイオベース接着剤の迅速な採用が主な理由です。
欧州では、専門的な外科手術において組織接着剤の利用が堅調に拡大しています。ドイツ、英国、フランスが主要な収益拠点となっており、2024年におけるドイツの市場規模は2億281万米ドルで欧州最大、次いで英国が1億5,290万米ドル、フランスが1億2,760万米ドルと予測されています。欧州の医療システムは入院期間の短縮や回復時間の短縮に注力しており、これは組織接着剤がもたらす効果と合致しています。
アジア太平洋市場の急成長を牽引しているのは、必要とされる外科手術件数の膨大さと、非侵襲的な創傷閉鎖法に対する認知の高まりです。2024年には中国が1億3,408万米ドルで市場をリードし、続いて日本が1億1,207万米ドル、インドが9,885万米ドルとなっています。これらの国々は、医療アクセスの拡大と外科手術件数の増加に支えられ、地域需要を支配しています。特に中国とインドの市場は、外傷症例の急増や民間・公的病院への投資拡大、さらには政府主導による手術用消耗品の国産化推進策によって急速に拡大しています。
当レポートでは、世界の組織接着剤の市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域/主要国別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global Tissue Adhesives Market Research Report by Type [Synthetic & semi-Synthetic Adhesives (Cyanoacrylates, Polyethylene Glycol, Gelatin-Formaldehyde, Others), Natural Adhesives (Fibrin, Collagen, Dextran, Chitosan, Others)], by Application [Surgery (Cardiovascular Surgery, Orthopedic Surgery, General Surgery, Neurosurgery, Plastic & Reconstructive Surgery, Ophthalmic Surgery, Urological Surgery, Thoracic Surgery, Others), Wound Care, Burn Treatment], by End User (Hospitals and Specialty Clinics, Ambulatory Surgical Centers, Research Laboratories & Institutes), and by Region (North America, Europe, Asia Pacific, Rest of the World) Forecast till 2035
The global tissue adhesives market is expected to reach USD 6.89 billion by 2035 at a CAGR of 9.06%. Tissue adhesives are medically specialized glues that are essentially beneficial for closing wounds in the skin. Moreover, by bonding to the tissue tightly and securely, they offer a less intrusion method of wound closure, thus generally leading to faster healing and better aesthetic results.
Innovation in bio-inspired, nanotechnology-enhanced, and polymer-based adhesives is transforming wound closure. These advancements improve bonding strength, cut closure times, and reduce infection risk, making tissue adhesives vital in modern minimally invasive surgeries. Enhanced delivery systems such as gels and sprays further accelerate adoption, positioning next-generation adhesives as a cornerstone of patient-centric, efficient, and sustainable surgical care worldwide.
Major Company Developments
B. Braun continues to strengthen its global footprint by emphasizing innovation, advanced technologies, and patient-centric healthcare solutions. The company invests heavily in R&D to develop next-generation products and improve existing ones, ensuring responsiveness to unmet medical needs. Its strategy revolves around four pillars-collaboration, cutting-edge integration, digital excellence, and customer alignment. In Hospital Care, the company is optimizing infusion pumps with integrated medication management systems. Aesculap focuses on expanding digital and robotic-assisted surgical solutions, while Avitum advances efficiency and connectivity in dialysis therapies. With ongoing refinement of chronic and acute treatment offerings, B. Braun is well-positioned to provide seamless, technology-driven solutions that enhance clinical efficiency, patient safety, and healthcare outcomes worldwide.
Major players in the global tissue adhesives market are Meyer Haake GmbH, Essity, Zhejiang Perfectseal, Baxter, Chemence Medical, Inc., H.B. Fuller Medical Adhesive Technologies, LLC., Becton, Dickson and Company (BD), B. Braun, Artivion, GEM SRL, Advanced Medical Solutions (AMS), and Cohera Medical, Inc.
Report Attribute Details
Market Size 2024 USD 2,649.88 Million
Market Size 2035 USD 6,892.51 Million
CAGR (2025-2035) 9.06%
Base Year 2024
Market Forecast Period 2025-2035
Historical Data 2019, 2022, 2023
By Type: Synthetic & Semi-Synthetic Adhesives - 8.30%, Natural Adhesives - 10.20%.
By Application: Surgery- 9.04%, Wound Care - 10.42%.
By End User: Hospitals and Specialty Clinics - 8.62%, Ambulatory Surgical Centers (ASCs) - 10.13%.
Regional Insights
North America is still the largest regional market by far, making up more than 40% of the total revenue share worldwide. The numerous cases of cardio-vascular, orthopedic, and reconstructive surgery have made tissue adhesives a must-have in modern surgical procedures. The U.S. dominates the North American tissue adhesives market with USD 913.72 million in 2024, while Canada follows with USD 199.90 million. The U.S. is still the most powerful country on the continent, primarily due to the large R&D investments and quick adoption of novel bio-based adhesives.
Europe demonstrates robust usage of tissue adhesives in specialized surgeries, where Germany, the UK, and France have been the major revenue centers. Germany is Europe's largest tissue adhesives market at USD 202.81 million in 2024, followed by the UK with USD 152.90 million and France with USD 127.60 million. The healthcare systems in Europe are focusing on shortened hospital stays and quicker recovery times, which is compatible with the effectiveness provided by tissue adhesives.
The drive behind the fast growth of the Asia-Pacific market is the huge volume of surgical procedures required and the increasing recognition of non-invasive wound closure methods. China tops the APAC tissue adhesives market with USD 134.08 million in 2024, followed by Japan at USD 112.07 million and India at USD 98.85 million. These countries dominate regional demand, fueled by expanding healthcare access and surgical procedures. China and India's markets are expanding rapidly due to a surge in trauma cases and rising investments in both private and public hospitals, supported by the government-backed initiatives to localize production of surgical consumables.
The Rest of the World market is growing steadily, led by Brazil's rise in cosmetic surgeries, Gulf states' investments in advanced healthcare, and gradual adoption in Africa, supported by global healthcare partnerships despite access and cost challenges.